Laboratory Criteria and Diagnostic Approach for Disseminated Intravascular Coagulation

Core Diagnostic Laboratory Findings

The presence of low platelet count (≤ 100 × 10⁹/L, especially ≤ 50 × 10⁹/L), prolonged prothrombin time (≥ 1.5 × mean normal), prolonged activated partial thromboplastin time (≥ 1.5 × mean normal and beyond what dilution alone would cause), elevated D‑dimer or fibrin‑degradation products, and fibrinogen < 1.0 g/L together are highly suggestive of DIC, with the combined D‑dimer/FDP measurement providing the highest diagnostic efficiency. 1, 2
Critically low fibrinogen (< 1.0 g/L) is a strong indicator of DIC. 1, 2
Prolongation of PT and aPTT beyond the degree expected from dilution, when accompanied by marked thrombocytopenia and fibrinogen < 1.0 g/L, strongly points toward DIC. 1

Antithrombin activity declines as consumptive coagulopathy progresses; falling levels correlate with greater severity and poorer prognosis. 3
Low or decreasing factor VIII and von Willebrand factor levels are characteristic of consumptive coagulopathy and help differentiate true DIC from chronic liver disease, where these factors are usually preserved. 3
In isolation, aPTT alone yields only about 57 % diagnostic efficiency, and platelet count alone about 67 % efficiency, underscoring the need for a combined panel. 1

DIC evolves rapidly; single‑time‑point measurements can be misleading. Serial testing (e.g., every 24–48 h) is strongly recommended to capture progressive changes in coagulation parameters. 1, 4, 5
Frequent reassessment of platelet count, fibrinogen, PT, and aPTT should be performed before overt microvascular bleeding becomes apparent. 1

Rapid (hour‑to‑day) shifts in coagulation test results favor true DIC over the relatively stable hemostatic re‑balancing seen in chronic liver disease. 4, 3
The presence of low/declining factor VIII and von Willebrand factor levels supports a consumptive process rather than liver‑related coagulopathy. 3
Clinical evaluation should actively seek DIC triggers (e.g., sepsis, trauma, malignancy) that may coexist with liver disease. 2, 6

In trauma patients, laboratory abnormalities that mimic DIC (prolonged PT/aPTT, low platelets/fibrinogen, high D‑dimer) often reflect hemodilution, shock, and hyper‑fibrinolysis rather than true micro‑thrombi formation. 7

Initial core panel: order platelet count, PT, aPTT, fibrinogen, and D‑dimer/FDP when DIC is suspected. 5
Pattern recognition: confirm the quartet of thrombocytopenia, prolonged PT/aPTT, elevated D‑dimer/FDP, and low fibrinogen. 1, 2
Repeat testing: obtain serial measurements within 24–48 h to identify dynamic trends. 1, 5
Confirmatory adjuncts: add antithrombin, factor VIII, and von Willebrand factor assays when differentiation from liver disease or other mimics is required. 3
Clinical correlation: always integrate laboratory data with the underlying clinical trigger (e.g., sepsis, malignancy, trauma, obstetric complications). 8, 9

The International Society on Thrombosis and Haemostasis (ISTH) recommends using the overt DIC scoring system, with a total score ≥ 5 indicating overt DIC; the score is derived from platelet count, prothrombin time (PT) prolongation, D‑dimer/FDP elevation, and fibrinogen level. 10
Platelet count contributes up to 2 points: 2 points for < 50 × 10⁹/L and 1 point for 50–< 100 × 10⁹/L. 10
PT prolongation contributes up to 2 points: 2 points for ≥ 6 seconds prolonged (PT ratio > 1.4) and 1 point for 3–< 6 seconds prolonged (PT ratio > 1.2 to ≤ 1.4). 10
Fibrinogen level contributes 1 point when < 1.0 g/L. 10
The scoring system places greater weight on fibrin‑related markers (D‑dimer/FDP) than on platelet count, emphasizing laboratory abnormalities over clinical signs. 10

For patients with sepsis, ISTH advises a two‑step strategy: first calculate the Sepsis‑Induced Coagulopathy (SIC) score; a score ≥ 4 identifies early‑phase (subclinical) DIC and prompts early intervention. 10
SIC score components and points:
- Platelet count < 100 × 10⁹/L = 2 points; 100–< 150 × 10⁹/L = 1 point. 10
- PT ratio > 1.4 = 2 points; 1.2 < PT ratio ≤ 1.4 = 1 point. 10
- SOFA score ≥ 2 = 2 points; SOFA = 1 = 1 point. 10
A positive SIC score (≥ 4) signals a phase where anticoagulant therapy may still be beneficial before overt coagulopathy develops. 10
Patients who meet SIC criteria should then be reassessed with the full ISTH overt DIC score to determine progression to overt disease. 10

Routine screening for overt DIC on ICU admission is associated with reduced mortality; repeating the screening after 48 hours further strengthens this survival benefit, suggesting that systematic DIC screening improves patient outcomes. 10